DACLATASVIR dihydrochloride (DCV), eq. 60mg base, break.tab.
STD
DORADACL6TB
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
04/10/2024, 17:00:17
6.4.4.2.1 - Pangenotypic direct-acting antiviral combinations
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AP07
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
DACLATASVIR (DCV)
Therapeutic Action
Inhibitor of the multifunctional protein NS5A
Indications
Chronic hepatitis C virus (HCV), in combination with other antiviral medicines
Instructions for use
To be used in combination with sofosbuvir, with or without ribavirin:
- In children, daclatasvir 60 mg is used in combination with sofosbuvir 200 mg.
- In adults, a fixed-dose combination (FDC) of daclatasvir 60mg / sofosbuvir 400mg is available.
Storage
Below 25ºC